Država: Združene države Amerike
Jezik: angleščina
Source: NLM (National Library of Medicine)
Cefoxitin Sodium (UNII: Q68050H03T) (Cefoxitin - UNII:6OEV9DX57Y)
SAMSON MEDICAL TECHNOLOGIES LLC
Cefoxitin Sodium
Cefoxitin 100 g
INTRAVENOUS
PRESCRIPTION DRUG
To reduce the development of drug-resistant bacteria and maintain the effectiveness of cefoxitin and other antibacterial drugs, Cefoxitin for Injection, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Cefoxitin for Injection, USP is indicated for the treatment of serious infections caused by susceptible strains of the designated microorganisms in the diseases listed below. - Lower respiratory tract infections, including pneumonia and lung abscess, caused by Streptococcus pneumoniae , other streptococci (excluding enterococci, e.g., Enterococcus faecalis [formerly Streptococcus faecalis ]), Staphylococcus aureus (including penicillinase-producing strains), Escherichia
Cefoxitin for Injection, USP is a dry white to off-white powder available in the following SmartPak® Pharmacy Bulk Package: 100 grams* (1 Pharmacy Bulk Package) Product No. 4100 NDC 66288-4100-1 sold in individual bags. *Each 100 gram Pharmacy Bulk Package contains sterile cefoxitin sodium equivalent to 100 grams of cefoxitin. SmartPak® system components are not made with natural rubber latex. Special storage instructions Cefoxitin for Injection, USP in the dry state should be stored between 2-25°C (36-77°F). Avoid exposure to temperatures above 50°C. The dry material as well as solutions tend to darken, depending on storage conditions; product potency, however, is not adversely affected.
Abbreviated New Drug Application
CEFOXITIN- CEFOXITIN INJECTION, POWDER, FOR SOLUTION SAMSON MEDICAL TECHNOLOGIES LLC ---------- CEFOXITIN FOR INJECTION, USP RX ONLY PHARMACY BULK PACKAGE – NOT FOR DIRECT INFUSION To reduce the development of drug-resistant bacteria and maintain the effectiveness of Cefoxitin for Injection, USP and other antibacterial drugs, Cefoxitin for Injection, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. DESCRIPTION: CEFOXITIN FOR INJECTION, USP, PHARMACY BULK PACKAGE BAG SMARTPAK® SHOULD BE USED ONLY IN PATIENTS WHO REQUIRE A 1 GRAM DOSE AND NOT ANY FRACTION THEREOF. CEFOXITIN FOR INJECTION USP, PHARMACY BULK PACKAGE BAG SMARTPAK® SHOULD NOT BE USED IN PATIENTS WHO REQUIRE LESS THAN THE 1 GRAM DOSE OF CEFOXITIN. Cefoxitin for Injection, USP is a semi-synthetic, broad-spectrum cepha antibiotic for intravenous administration. It is derived from cephamycin C, which is produced by _Streptomyces lactamdurans_. Its chemical name is sodium (_6R,7S_)-3-(hydroxymethyl)-7-methoxy-8-oxo-7-[2-(2-thienyl)acetamido]-5- thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate carbamate (ester). The empirical formula is C H N NaO S , and the structural formula is: Cefoxitin for Injection contains approximately 53.8 mg (2.3 mEq) of sodium per gram of cefoxitin. Solutions of Cefoxitin for Injection, USP range from colorless to light amber in color. The pH of freshly constituted solutions usually ranges from 4.2 to 7.0. BEFORE ADMINISTRATION, THIS PHARMACY BULK PACKAGE REQUIRES RECONSTITUTION USING STERILE WATER FOR INJECTION, USP TO A CONCENTRATION OF 100 MG PER ML AND FURTHER DILUTION IN 50 ML OF A COMPATIBLE SOLUTION AND INFUSED INTRAVENOUSLY. THIS PRODUCT IS NOT INTENDED TO BE USED IN PEDIATRIC AND RENALLY IMPAIRED PATIENTS WHO REQUIRE LESS THAN A 1 GRAM DOSE. Each SmartPak Pharmacy Bulk Package contains sterile Cefoxitin Sodium, USP equivalent to 100 grams of cefoxitin and is intended for intravenous infusion only. A Pharmacy Bulk Package is a container of a sterile p Preberite celoten dokument